Related Experiment Video
Updated: May 9, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Atypical pathogens causing community-acquired pneumonia in adults
Ali Bin Sarwar Zubairi1, Afia Zafar, Nawal Salahuddin
1Department of Medicine, Aga Khan University, Karachi, Pakistan. ali.zubairi@aku.edu
JPMA. the Journal of the Pakistan Medical Association
|July 23, 2013
Summary
Atypical organisms like Mycoplasma pneumoniae and Chlamydia pneumoniae are common causes of community-acquired pneumonia (CAP) in Karachi. Local CAP treatment guidelines should target these specific pathogens.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Community-acquired pneumonia (CAP) poses a significant public health challenge globally.
- Identifying the etiologic agents of CAP is crucial for effective treatment and management.
- Atypical pathogens are increasingly recognized as important contributors to CAP.
Purpose of the Study:
- To determine the frequency of respiratory pathogens causing CAP.
- To specifically investigate the prevalence of atypical organisms in CAP patients.
- To inform local treatment strategies for CAP.
Main Methods:
- A descriptive study was conducted on 124 adult patients diagnosed with CAP.
- Diagnostic methods included antibody titers for Mycoplasma pneumoniae and Chlamydia pneumoniae, and bacterial antigen tests for Legionella pneumophila.
- Respiratory secretions and blood cultures were used to identify pyogenic bacteria.
Main Results:
- An etiologic agent was identified in 35.4% of the 124 patients.
- Mycoplasma pneumoniae was the most frequent pathogen (17%), followed by Chlamydia pneumoniae (12%).
- Streptococcus pneumoniae was the most common organism in blood cultures; no Legionella pneumophila was detected.
Conclusions:
- Mycoplasma pneumoniae and Chlamydia pneumoniae are significant causes of CAP in Karachi.
- Current local treatment guidelines for CAP should incorporate specific therapies for these atypical agents.
- Further research into regional pathogen prevalence is warranted to optimize CAP management.
Related Concept Videos
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: